Counsel Portfolio Services’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-16,972
Closed -$6.86M 276
2015
Q2
$6.86M Sell
16,972
-5,499
-24% -$2.21M 0.7% 29
2015
Q1
$9.49M Buy
22,471
+1,567
+7% +$618K 0.95% 14
2014
Q4
$7.1M Sell
20,904
-879
-4% -$284K 0.72% 34
2014
Q3
$7.21M Sell
21,783
-4,774
-18% -$1.57M 0.75% 31
2014
Q2
$8.37M Sell
26,557
-6,813
-20% -$2.05M 0.79% 23
2014
Q1
$10.2M Buy
33,370
+574
+2% +$182K 1.03% 17
2013
Q4
$9.17M Sell
32,796
-2,734
-8% -$707K 0.94% 23
2013
Q3
$8.55M Buy
35,530
+4,836
+16% +$1.08M 0.42% 25
2013
Q2
$6.61M Buy
+30,694
New +$6.56M 0.8% 28

Other funds holding BIIB

Counsel Portfolio Services's BIIB Position: Q3 2015 in Review

Counsel Portfolio Services sold out of Biogen (BIIB) in Q3 2015, closing a stake of 16,972 shares — an estimated $6.86M sold.

Counsel Portfolio Services first reported a position in BIIB in Q2 2013 and held it in 9 quarters. The position peaked at $10.2M in Q1 2014. 924 funds tracked by Wall St. Rank hold BIIB as of Q3 2015.

  • Counsel Portfolio Services reported no remaining Biogen position as of Q3 2015 after selling out during the quarter.
  • Counsel Portfolio Services sold 16,972 Biogen shares in Q3 2015, an estimated $6.86M.
  • Counsel Portfolio Services first reported a position in Biogen in Q2 2013 and held it in 9 quarters.
  • Counsel Portfolio Services's Biogen position peaked at $10.2M in Q1 2014.
  • 924 funds tracked by Wall St. Rank held Biogen as of Q3 2015.

Based on Counsel Portfolio Services's 13F filing for Q3 2015, filed 13 Nov 2015.